Gambogic acid reverses oxaliplatin resistance in colorectal cancer by increasing intracellular platinum levels

Resistance to oxaliplatin (L-OHP) is a major obstacle to successful chemotherapy in colorectal cancer (CRC). In the present study, the ability of gambogic acid (GA) to reverse L-OHP resistance in CRC LoVo cells was investigated. L-OHP-resistant LoVo/L-OHP cells were established by exposing them to i...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Qiang, Wei, Jianchang, Wang, Chengxing, Zhang, Tong, Huang, Di, Wei, Fang, He, Feng, Cai, Wensong, Yang, Ping, Zeng, Shanqi, Li, Wanglin, Cao, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6036459/
https://www.ncbi.nlm.nih.gov/pubmed/30008940
http://dx.doi.org/10.3892/ol.2018.8916

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6036459/
https://www.ncbi.nlm.nih.gov/pubmed/30008940
http://dx.doi.org/10.3892/ol.2018.8916

Ejemplares similares